Schedule 13G ownership disclosure
Protara Therapeutics Inc
Common Stock · CUSIP: 74365U107
Event date: 2025-12-31
- Filing-level shares
- 2,408,868
- Percent of class
- 4.7%
- BlackRock, Inc.
Shares: 2,408,868 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-000705
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership